The influence of acute and chronic lithium administration on inositol content was examined in five different regions of the rat brain: caudate, cerebellum, cortex, hippocampus and hypothalamus. After acute administration of lithium at doses of 3, 6 or 10 mEq kg −1 , no significant reductions of inositol were found in any brain region. Also no significant changes were observed in cortex, caudate, hippocampus and cerebellum after chronic treatment with lithium-containing diet, which led to brain concentrations of lithium in the therapeutic range. However, a moderate but significant reduction of inositol was under these conditions observed in the hypothalamus. At basal conditions, ie in control rats not treated with lithium, the inositol content in various brain areas was different, the hypothalamus containing the highest inositol concentration (4.4 mmol kg −1 wet weight) and the cortex the lowest (2.3 mmol kg −1 wet weight). It is concluded that chronic lithium treatment at therapeutically relevant brain concentrations does not evoke major changes in the inositol content of the brain but induces a moderate decrease which is restricted to the hypothalamus. The results are discussed with respect to the potential function of the hypothalamus in affective disorders.
Introduction
which is most probably altered in affective disorders (for review see Ref. 4 ). Lithium remains the primary agent for both the treat-
The inositol depletion hypothesis gained considerment of acute manic episodes and for the maintenance able attention due to the fact that it apparently offered treatment of bipolar affective disorder.
1 Its mode of an explanation for the hitherto unexplained property action, however, is still elusive, although evidence has of lithium to specifically influence only the altered accumulated that its action on cellular second messenmood of individuals with affective disorders, leaving ger systems might be a key to the comprehension of the almost unaffected the psychological functioning of norbiochemical mechanisms of its effects. The reappraisal mal subjects. According to the hypothesis, this unique during the last decade of the possible role of signal feature was due to firstly, the uncompetitive nature of transduction pathways in lithium's mode of action 2 lithium's inhibitory effects on inositol monophosphatwas particularly stimulated by Berridge's seminal ase, which results in an inhibition that is the more pro-'inositol depletion hypothesis' (for review see Ref. 3) .
nounced the more substrate for the enzyme is available, This hypothesis postulates that, since the entry of and secondly to the fact that the more frequently the inositol into the brain is limited, the inhibition by lithsystem is stimulated the more inositol phosphates ium of the hydrolysis of inositol phosphates to inositol accumulate at the expense of inositol. It was conresults in a depletion of the brain of inositol, which in cluded 3 from these unusual properties of lithium's turn compromises the resynthesis of inositol phospholeffect on this system that a pronounced inhibition by ipides and subsequently also the formation of inositol lithium of the inositol phospholipid second messenger trisphosphate (IP 3 ) and diacylglycerol (DAG) from system would occur only under conditions, where the these membrane lipids. These second messenger molrespective receptors and their signal transducing sysecules are of particular importance in the signal transtem are pathologically overactivated. duction of neurotransmitter systems such as noradrenAlthough attractive and seminal, the 'inositol aline, acetylcholine and serotonin, the function of depletion hypothesis' has been questioned on the grounds that even with toxic doses of lithium the brain's depletion of inositol is only small and might be restricted to acute treatment with lithium salts. Fur-treated rats, these effects were apparently due to an HPLC separations. A 10-porasil column (4.6 × 300 mm) (Grom/Herrenberg-Kayh, Germany) was utilexaggerated depletion of inositol in this slice system and were not observed in other species, in which the ized. The frozen tissue was thawed and roughly homogenized with a spatula, while kept on ice. To an aliquot supply of inositol is not compromised as readily (for review see Refs 5,6). It has been argued, however, that of 5-15 mg of each sample, 500 l of deionized water was added, then vortexed for 10 s. The samples were a lithium-induced depletion of inositol might be limited to selected brain areas or even cells that might be deproteinated by heating to 95°C for 5 min. After vortexing once more, the homogenates were centrifuged at particularly vulnerable to this effect due eg to restricted inositol supply and/or an increased activity of the 13 000 g for 30 min at 5°C. The entire supernatant was transferred to 2-ml plastic tubes containing 20 units inositol phospholipid second messenger system (for review see Refs 5,7). We have therefore measured the glucose oxidase. The tubes were then incubated for 40 min at 37°C in a shaking water bath. Aliquots of 50 l effect of both acute and chronic treatment with lithium on the inositol content in various areas of rat brain. The of each sample were transferred to glass tubes (Assistent/Sondheim-Rö hn, Germany) containing results indicate that after chronic treatment a lithiuminduced decrease in inositol is significantly evident 0.2 l epi-inositol as internal standard. The probes were evaporated in a vacuum-centrifuge (Speed vac only in the hypothalamus.
200, Bachofer, Reutlingen, Germany), followed by addition of 200 l of a freshly prepared solution of Materials and methods 20% (w/v) p-nitrobenzoyl-chloride in pyridine to each sample. After mixing, samples were incubated for 90 Animal experiments were performed in Israel. After decapitation of the rats and dissection of the brain min at 60°C. The reaction was stopped by adding a few drops of deionized water until a solid pellet formed. areas, tissue samples were sent to Germany for inositol determination.
Immediately 2 ml of chloroform were added and the pellet was dissolved by vortexing vigorously. Six extractions were performed with twice 2 ml deionized Animals water, twice 2 ml 5% NaHCO 3 (w/v) and twice 3 ml 1 N HCl. Following each extraction the samples were Experiment 1: acute lithium Male rats (SpragueDawley) weighing 250-300 g were injected intrapericentrifuged for 1 min to separate the phases and the aqueous phase was eliminated. Twenty microliters of toneally (i.p.) with either 3 mEq kg −1 LiCl, 6 mEq kg
LiCl or 10 mEq kg −1 LiCl or the same volume of NaCl the organic phase were injected into a 10-porasil column, utilizing hexane-chloroform-acetonitrile isotonic solution. Twenty four hours later rats were killed by decapitation and the brains removed onto ice.
(10 : 3 : 2) and water 0.1% as mobile phase. The flow rate was 1.5 ml min −1
. The integrator was calibrated Fresh brains were dissected into five regions: hypothalamus, cortex, cerebellum, caudate and hippocamusing pure standards between 0 and 1.5 g for myoinositol and 0 and 0.5 g for epi-inositol (used for deripus. Samples were coded and batched in a balanced design, stored at −70°C until assay and shipped to the vatization; finally injected 0-15 ng and 0-5 ng respectively). UV detection was at 254 nm. Retention German laboratory for HPLC analysis blind to the treatment of each sample. times were about 12 min for myo-inositol and 14 min for epi-inositol respectively. Each sample was analyzed in duplicate. Experiment 2: chronic lithium Rats were fed with food containing 0.2% LiCl or regular food for 21 days. Separate bottles of water and 0.9% NaCl solution were
Determination of lithium provided ad libitum for both groups of animals. After
To an aliquot of 50 mg of each sample, 500 l of per-21 days, animals were killed by decapitation, the fresh chloric acid (10%) were added. After vortexing, the brains were dissected into five regions (see above).
homogenates were centrifuged at 13 000 g for 30 min Blood Li levels were measured in carotid blood and at room temperature. The entire supernatant was filled were found to be 0.79 ± 0.16 mM. Brain samples were up to 2.5 ml with 0.45 mM CsCl-solution and samples coded and batched in a balanced design, stored at were analyzed by flame emission spectroscopy −70°C until assay and shipped for HPLC analysis blind (Elektrolytautomat FL 6/Zeiss, Stuttgart, Germany). to the treatment of each sample.
Determination of inositol Statistics
For the acute experiment (control vs 3 mEq/ All reagents were purchased from Merck (Darmstadt, Germany) with the exception of glucose oxidase and 6 mEq/10 mEq), means of each brain area were compared using ANOVA (one-way) with a priori comparipyridine, which were from Sigma (Munich, Germany). Pyridine was kept dry by storing over a molecular sieve son (group mean of control rats is greater than at least one group mean of the lithium-treated rat groups). In 0.4 nm (Merck). Solvents for the mobile phase and chloroform for dissolving the derivatives were all the chronic experiment group differences were analyzed using Student's t-test for independent samples. HPLC grade. All other chemicals were analytical grade. A Waters HPLC system of Waters 501 pump and a WatControlling for the increase in type I error rate, we applied the Bonferroni-Holm method. ers 486 UV detector set at 254 nm were used for all
Results
lowest inositol content appears to be quite consistent among experiments, irrespective of the different treatBrain lithium ments (NaCl injection or no treatment) the animal Only data of cortex, cerebellum and hippocampus are received. given, because material from the other regions was insufficient to determine the lithium concentration.
Brain inositol after lithium-treatment Twenty-four hours after a single injection of 3 mEq A single dose of 3 mEq LiCl kg −1 did not lower inositol kg −1 LiCl the concentration of lithium in brain was concentrations in any brain region (Figure 1 ). In conabout 0.4 mmol kg −1 wet weight (means ± s.d.: cortex: trast, at higher doses of LiCl (6 and 10 mEq kg
) inosi-0.4 ± 0.11; cerebellum 0.34 ± 0.14; hippocampus 0.35 tol levels appeared slightly reduced in all brain regions ± 0.05 mmol kg −1 wet weight). However, 24 hours after with the exception of the hypothalamus. However, a single dose of the higher lithium concentrations these effects did not reach statistical significance, when (6 mEq kg −1 and 10 mEq kg −1 ), brain lithium was about the ␣-level (0.05) was corrected for multiple testing two to three times higher for 6 mEq LiCl (cortex: 1. 35 (five areas, three concentrations). ± 0.43; cerebellum: 0.9 ± 0.22; hippocampus 1.19 ± 0.14 After chronic dietary administration of LiCl, a sigmmol kg −1 wet weight) and about six to nine times nificant reduction of inositol was found only in the higher for 10 mEq LiCl kg −1 (cortex: 2.5 ± 0.82; cerebelhypothalamus (P Ͻ 0.01; ␣-level = 0.05/5) whereas no lum: 2.0 ± 0.77; hippocampus: 3.15 ± 0.38).
effect was found in the other brain areas (Figure 2 ). Chronic dietary treatment with lithium-containing diet (0.2% LiCl w/w) ad libitum resulted in brain lithium levels in the therapeutical range (cortex: 0.73 ± Discussion 0.12; cerebellum: 0.54 ± 0.13; hippocampus: 0.62 ± In the present study we compared the effects of acute 0.14).
and chronic treatment with lithium on the inositol content in various areas of the rat brain. A slight but statBrain inositol at control conditions istically not significant reduction in the level of inosiRemarkable differences in the inositol content in the tol was, after acute treatment, only observed at lithium various brain areas were observed at control conditions doses of 6 mEq kg −1 and higher (Figure 1 ). However, (Table 1 ). Both in rats that received only control diet (Table 1A ) and in rats receiving additionally NaCl injections as a control treatment (Table 1B) , the inositol content was highest in the hypothalamus and lowest in the cortex, the other brain areas expressing intermediate inositol content. Similar results have been found in our previous publication. 8 Whereas the absolute values of the inositol content of the other regions vary somewhat between experiments, the finding that hypothalamus expresses the highest and cortex the Statistically significant were differences between:
A: Hypothalamus and hippocampus: P Ͻ 0.001; hypothala- Figure 1 Effect of acute lithium on inositol concentration in mus and cerebellum: P Ͻ 0.001; hypothalamus and caudavarious brain regions. Twenty-four hours after i.p. application tum: P Ͻ 0.001; hypothalamus and cortex: P Ͻ 0.001; hipof 3, 6, and 10 mEq kg −1 lithium chloride, rats were killed by pocampus and cortex: P = 0.001; cerebellum and cortex: decapitation, and the brain regions dissected and frozen in P = 0.001.
liquid nitrogen until determination of myo-inositol by HPLC as described in Materials and Methods. ANOVA (one-tailed) B: Hypothalamus and cortex: P = 0.003; hypothalamus and as compared to controls (n = 24) was at 6 mEq kg −1 significant hippocampus: P = 0.008; hippocampus and cortex: P = for hippocampus (n = 17; P = 0.042) and at 10 mEq kg −1 for 0.012; cerebellum and cortex: P = 0.005. cerebellum (n = 17; P = 0.042) and cortex (n = 17; P = 0.033), if the ␣-level is retained at 0.05. However, no significant ␣-values were corrected for multiple testing according to Bonferroni-Holm 26 already toxic range lead, if anything, only to a very moderate decrease of inositol.
However, we observed after chronic treatment and at brain concentrations within the therapeutic range, a clear-cut reduction of the inositol content in the hypothalamus, while all other brain areas did not differ from controls. This reduction was significant even after Bonferroni-correction for multiple testing (five areas). No 9, 11, 15 or only minute 10 reductions of the inositol content in various rat brain areas have been found after chronic treatment with lithium given either as daily injection (3.5 or 2.5 mEq kg −1 ) 9, 11 or in the diet, 10,15 and dietary lithium was even reported to increase cortical inositol by 30%. 15 In agreement with most reports (but in contrast with Whitworth and Kendall's 15 finding of an increased inositol content in cerebral cortex) we found no alteration of inositol after chronic lithium treatment in four of the five brain areas examined. Thus after chronic lithium treatment there appear to be no major changes of the inositol content of the brain, with the exception of the hypothalamus. This region has, to earlier observation 8 that the hypothalamus is, at control conditions, the brain region with the highest inositol content (Table 1) . We have also previously shown For the discussion of the potential interrelation of these findings and their underlying mechanisms, it has to be in rat brain at high acute lithium doses have been described by others in some [9] [10] [11] but not all 12 rat strains. considered which factors govern the inositol content of cells and tissues. Four processes contribute to the Reductions in the inositol content up to 35% have been reported by Sherman and associates for cerebral corregulation of the intracellular inositol content (for a review see Ref. 17) . Two of these, the formation via tex, 10 although the lithium levels measured in the brain in their experiments were approximately similar to breakdown of phosphoinositides and the de novo synthesis from glucose-6-phosphate comprise as the last those in ours. 10 More pronounced reductions in inositol were reported by Hirvonen and Savolainen.
11 These step the hydrolysis of inositolmonophosphate and are therefore sensitive to inhibition by Li + -ions. The third authors, however, found lithium concentrations in the brain more than twice as high as in our study. Agam process involves a Na + -dependent high affinity uptake system, which transports inositol against a concenet al 13 found no significant reduction of brain inositol after an acute injection of 3 mEq kg −1 , although 10 mEq tration gradient from extracellular inositol concentrations in the M range to approximately 2-10 mM kg −1 did reduce cortical inositol. 14 Strain differences and/or different methods of application of lithium as intracellularly and which appears to operate at close to maximal capacity under physiological conditions. In well as the interval between application and sampling may be responsible for these variable results. It should, addition a Na + -independent, low affinity component is frequently observed, which perhaps represents simple however, be noted that our failure to find any significant reduction of the inositol content after acute lithor facilitated diffusion and may be regarded as an inositol efflux route at normal extracellular concenium treatment does not necessarily contradict the positive finding by others, 9-11 since we were interested in trations. Thus the higher inositol content in hypothalamus as compared to the other brain regions could be the effects in various brain regions and had therefore to lower the ␣-level for multiple testing with an inevitable due to either increased intracellular formation (via phosphoinositide breakdown and/or de novo increase in type II error. In summary, as already concluded from the data obtained by other groups (for synthesis) or increased uptake via the high affinity transport system or both. The hypothalamus differs review see Ref. 5), our data also indicate that acute treatment with lithium at doses within the therapeutic from the other brain regions in having only a weak blood-brain barrier, which might facilitate diffusion of range does not induce a depletion of inositol in various areas of rat brain and even doses in the presumably inositol from the plasma into this area. This fact might perhaps explain, why inositol given at very high con-(HPA) axis resulting in hypercorticolism and blunted response to dexametason is associated with both manic centration i.p. accumulates more rapidly and efficiently in hypothalamus than in other brain and depressive episodes (for a recent review see Ref.
21). The overactivity of the hypothalamic CRHregions 8 but cannot be responsible for the higher inositol content of this area at normal plasma concentrations secreting neurons, which is believed to be the essential driving force for the disturbed HPA regulation in (M), since under these conditions inositol has to be taken up into the cells against a large concentration affective disorder and perhaps for the pathophysiology of the illness in general (for review see Refs 22,23) gradient.
The four mechanisms mentioned above not only govmight be due to an increased activation of the inositolphospholipid second messenger system in the hypoern the inositol content of certain brain cells and areas at basal conditions but their relative impact also stiputhalamus. 19 The specific inhibition by lithium found in the present study indicates that the very area, the lates the particular sensitivity of cells to the inositoldepleting effect of lithium. As already postulated by overactivity of which is supposed to be central to the pathophysiology of affective disorder, might be partithe original inositol depletion hypothesis, lithium's depleting effect will be the more pronounced the more cularly prone to the inhibitory effect of lithium. The decrease in the content of inositol found in the frequently the inositol phospholipid hydrolysis is stimulated. However, those cells or brain regions that hypothalamus of these 'normal' rats is relatively small and it might therefore be doubtful, whether or not this exhibit a particularly active high affinity transport for inositol should be able to replenish inositol and/or moderate deficit could alter any physiological response. However, since the magnitude of the effect acquire cellular reserves during periods of rest and thereby counterbalance the effect of lithium. On the of lithium is, as discussed above, determined by the degree of activation of inositolphospholipid breakother hand, the effect of lithium would be reinforced by an increased activity of the low affinity, high down, a pathological overactivation of the HPA-axis as supposed to occur in the affective illness might result capacity efflux route.
The present data do not allow any conclusion, as to in a more relevant depletion of inositol in the hypothalamus as a consequence of lithium treatment. whether one of these mechanisms might apply for the hypothalamus and thus explain the restriction of lithFurther work involving animal models of affective disorder 24,25 is clearly required to elucidate the effect of ium's effect to this area. However, one possible explanation might be that under the conditions of the experistress on the activity of the inositol phospholipid second messenger system in the hypothalamus and its ments the breakdown of phospholipids in cells of the hypothalamus is particularly highly stimulated. The modification by chronic lithium treatment.
In conclusion we have shown that little if any rats experience, during treatment with lithium, considerable chronic stress, 18 that might lead eg via noraddecrease of inositol is evident in most brain areas after both acute and chronic treatment with lithium but that renergic, serotonergic and cholinergic pathways to the activation of receptors (␣ 1 , 5HT 2 , muscarinic) in the a significant reduction is observed in the hypothalamus after chronic application. The present results of restrichypothalamus, which are coupled to the inositolphospholipid second messenger system. Indeed, both phortion of lithium depletion of inositol to hypothalamus provide a possible heuristic synthesis between biobolester (which mimics the action of DAG on protein kinase C) and elevation of intracellular Ca 2+ have been chemical data on inositol depletion by lithium and previous in vivo studies that were unable to find clear found to induce secretion of CRH in vitro (for review see Ref. 19) . depletion in cortex, cerebellum, striatum or hippocampus. Thus, our result that lithium's effect after chronic treatment is restricted to the hypothalamus appears to be in line with the contention already raised in the
